ACTN2 and head and neck squamous cell carcinoma: In brief, findings in the current study indicate that MYL1, ACTN2, LAT, AC114730.3 and AC136375.3 may play roles as HNSCC suppressors, while RYR3 may function as a HNSCC promoter.